AMNEAL PHARMACEUTICALS, INC. Proceeds from Issuance of Secured Debt
AMNEAL PHARMACEUTICALS, INC. (AMRX) reported Proceeds from Issuance of Secured Debt of $2.69 billion for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfSecuredDebt · last filed 2025-11-06
- 2025-09-30: Proceeds from Issuance of Secured Debt 9 month $2.69B.
- 2024-09-30: Proceeds from Issuance of Secured Debt 9 month $0.00.
| Period end | Proceeds from Issuance of Secured Debt 9 month |
|---|---|
| 2025-09-30 | $2.69B 10-Q · filed 2025-11-06 |
| 2024-09-30 | $0.00 10-Q · filed 2025-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |